VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,508,895 | -42.6% | 792,526 | -18.8% | 0.00% | -33.3% |
| Q2 2023 | $18,302,400 | +36.0% | 976,128 | +4.6% | 0.00% | 0.0% |
| Q1 2023 | $13,456,269 | -19.1% | 933,167 | +8.6% | 0.00% | 0.0% |
| Q4 2022 | $16,623,624 | -52.1% | 859,102 | -15.0% | 0.00% | -57.1% |
| Q3 2022 | $34,718,000 | +79.8% | 1,010,708 | -20.0% | 0.01% | +75.0% |
| Q2 2022 | $19,305,000 | -63.9% | 1,263,384 | -46.1% | 0.00% | -55.6% |
| Q1 2022 | $53,538,000 | -63.1% | 2,346,047 | -40.4% | 0.01% | -60.9% |
| Q4 2021 | $145,251,000 | -32.0% | 3,939,508 | -14.3% | 0.02% | -36.1% |
| Q3 2021 | $213,551,000 | -8.0% | 4,594,226 | +15.9% | 0.04% | -7.7% |
| Q2 2021 | $232,082,000 | – | 3,965,479 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $661,184,000 | 13.47% |
| Casdin Capital, LLC | 3,038,167 | $183,050,000 | 4.65% |
| Logos Global Management LP | 758,265 | $45,685,000 | 3.84% |
| Novo Holdings A/S | 793,265 | $47,794,000 | 2.12% |
| Redmile Group, LLC | 1,936,530 | $116,676,000 | 1.73% |
| Cormorant Asset Management, LP | 709,224 | $40,594,000 | 1.38% |
| Rock Springs Capital Management LP | 962,826 | $58,011,000 | 1.15% |
| Asymmetry Capital Management, L.P. | 24,790 | $1,494,000 | 1.03% |
| Darwin Global Management, Ltd. | 103,013 | $6,207,000 | 1.00% |
| RA Capital Management | 880,284 | $53,037,000 | 0.85% |